Retrospective analysis of the use of osteoporosis medication at the presentation of fragility fractures in a predominantly Hispanic population.
A. Torres-Reveron, M. J. Serra-Torres
The paper examines osteoporosis medication use in a Hispanic population with fragility fractures, finding 42% received prophylactic treatment, with higher rates linked to age and insurance.
bioRxiv · Dec 24, 2020Pharmacology & Toxicology